The total cumulative deaths due to COVID-19 in Indonesia currently exceeds 20,000 people while new positive cases continue to exceed 6,000 cases daily since last week.
Based on the data issued by the National Agency for Disaster Management (BNPB) on its official Twitter page today, 205 more deaths had occurred.
This brought the overall deaths total to 20,085 people while 6,848 new cases were recorded in the last 24 hours boosting the overall positive cases to 671,788 cases.
The Jakarta Province continued to record the highest overall positive cases, namely, 164,557 cases with the overall death total at 3,087 people.
Starting from Dec 18, the Jakarta authorities had made it mandatory to those leaving and entering the province to undergo swab or rapid antigen test.
Meanwhile, Indonesian Finance Minister, Sri Mulyani Indrawati was quoted by Antara as saying that the cost of financing vaccine for the people of Indonesia was estimated at Rp54.44 trillion.
On Dec 16, Indonesian president, Joko Widodo announced that COVID-19 vaccine would be given free to the people in the country.
Indonesia, through the Eijkman Institute for Molecular Biology, a body under the Ministry of Research and Technology, had co-operated with a biopharmaceutical company from China, namely, Sinovac Biotech to conduct a research on COVID-19 vaccine.
Through the co-operation, Indonesia was also developing the Red and White vaccine (vaksin Merah Putih) after the colours of the national flag and was expected to be able to produce 290 million doses of vaccine by the middle of next year.
On Dec 6, Indonesia also received 1.2 million doses of COVID-19 vaccine from China while 1.8 million more doses of the vaccine would be received in early January next year.
Source: BERNAMA News Agency